CHARGED ALPHATMFrontier AI stock research

CALM · NasdaqGS

Cal-Maine Foods, Inc.

Farm Products · United States

USD 66.56-2.9% daily changeQuote 2026-09-30 · USD
Market cap (USD)
US$3.11B
Trailing P/E
10.04x
Forward P/E
30.05x
Quarterly revenue growth
-49.9%
Trailing net margin
10.9%
Indicated dividend yield
7.2%

Snapshot 2026-09-30 · Latest financial period 2026-05-30 · Yahoo Finance. Quotes may be delayed; reporting periods can differ.

Company background

Cal-Maine Foods, Inc., together with its subsidiaries, engages in the production, grading, packaging, marketing, and distribution of shell eggs, egg products, and prepared foods in the United Sates. It operates through Conventional Shell Eggs, Specialty Shell Eggs, and Prepared Foods segments. The company offers specialty shell eggs, including cage-free, organic, brown, free-range, and pasture-raised and nutritionally enhanced eggs, as well as conventional and co-pack shell eggs. It also provides prepared food products, such as pre-cooked egg patties, omelets, folded and scrambled egg formats, hard-cooked eggs, pancakes, waffles, and specialty wraps. The company offers its products under the Egg-Land's Best, Land O' Lakes, Farmhouse Eggs, Sunups, 4Grain, Van's, MeadowCreek Foods, and Crepini brand names. It sells its products to various customers, including national and regional grocery store chains, club stores, independent supermarkets, foodservice distributors, and egg product consumers. Cal-Maine Foods, Inc. was founded in 1957 and is headquartered in Ridgeland, Mississippi.

Company website

Q1 FY2027

Go beyond the headline.

CALM Stock: Better Egg Mix, Weaker Profits — Q1 FY2027

Published 2026-09-30

Q1 FY2027 REPORT HIGHLIGHTS

What’s changed for CALM

Cal-Maine’s specialty and prepared-food share rose to 54.1%, but every reportable segment earned less; cash, normalized profits and the dividend recovery hurdle decide the value.

  1. Mix rose while profits fell.

    Specialty and Prepared Foods reached 54.1% of external sales versus 37.1%; both segments produced lower revenue and lower income.

  2. Conventional pricing drove the loss.

    Average selling price fell 59.3%, while volume fell only 0.7%; Conventional lost $71.0 million.

  3. Liquidity bought time, not a dividend.

    Cash and available-for-sale securities were $767.6 million, down $156.5 million from year-end; the cumulative dividend recovery hurdle is $94.5 million.

  4. Capacity is still ahead of contribution.

    Prepared Foods volume fell 19.3% during expansion and optimization; the greater-than-60% capacity plan targets first-half FY2028, not a promised sales growth rate.

  5. Price already assumes recovery.

    The $68.55 reference is the September 29 close, before this print; our $58 base value depends on normalized profits rather than today’s losses.

Comparable businesses

CALM peer comparison

Same business group first, then company size. Preferred market cap: 0.5–2x; extended range: one-third–3x. Outside that range, industry benchmarks are labeled separately and excluded from peer medians.

Comparison stocks

Market metrics · missing or inapplicable values shown as —
MetricCALMCal-Maine Foods, Inc.Snapshot 2026-09-30Financial period: 2026-05-30TSNTyson Foods, Inc.Snapshot 2026-09-29Financial period: 2026-06-27BGBunge Global SASnapshot 2026-09-29Financial period: 2026-06-30
Market capMarket value, converted to USDUS$3.11BUS$17.91BUS$20.70B
Forward P/EProvider forward earnings estimate30.05x12.33x9.57x
EV / EBITDAEnterprise value / trailing EBITDA4.92x9.13x12.37x
Revenue growthLatest quarter vs prior-year quarter-49.9%-0.1%88.3%
Operating marginLatest reported quarter-11.0%2.7%4.6%
Free cash flow yieldTrailing cash flow / market cap0.3%6.7%-31.3%
Net debt / EBITDANet debt / trailing EBITDA-1.98x2.62x5.21x
Debt / equityTotal debt / positive book equity—0.44x0.98x
Trailing P/ETrailing twelve-month earnings10.04x31.43x23.22x
Price / bookPrice / positive book equity per share1.19x0.99x1.30x
EV / salesEnterprise value / trailing revenue0.79x0.45x0.42x
Earnings growthLatest quarter vs prior-year quarter—204.1%33.0%
Gross marginTrailing twelve months23.1%6.6%4.9%
Net marginTrailing twelve months10.9%1.0%1.1%
Return on equityProvider trailing return; positive equity only12.2%3.3%7.2%
Free cash flow marginTrailing free cash flow / revenue0.3%2.1%-7.1%
Dividend yieldIndicated annual dividend / price7.2%4.0%2.7%
Earnings payoutProvider trailing dividend payout72.4%125.3%60.8%
Current ratioCurrent assets / current liabilities7.70x1.43x1.57x
BetaProvider historical market sensitivity0.210.370.66

Choose a comparison stock

Search covered companies, or search all listed stocks.

Comparison methodology & limitations

Reviewed operating groups override broad sector classifications. Other companies are matched only within a sufficiently specific provider industry. Business mix, geography and accounting standards can still differ. Market caps are converted to USD using exchange rates captured during the snapshot refresh. Financial ratios that would mix currencies are omitted. Snapshots must be at most 14 days old and no more than seven days apart for automatic selection.

Peer medians require at least two valid similar-size peers for each metric. Negative earnings, nonpositive equity, missing data and irrelevant bank ratios are not presented as attractive valuations. A higher or lower number is not automatically a better investment. Financial statement periods are not calendar-aligned across companies.

Reported performance

Financial trends

Reporting period
Financial history
Chart style
Comparison stocks

Financial statements load separately from the research page.

Market context

Valuation & price history

Adjusted closing price

Price history

Price history loads separately.

Earnings-multiple scenario

Illustrative price = your earnings-per-share assumption × your P/E assumption. This is not a price target or a complete valuation model.

Starting assumptions, when available, use provider forward estimates as of 2026-09-30. Negative earnings require a different valuation method. This calculation omits balance-sheet, dilution and execution risks.

THE RESEARCH RECORD

Research history for CALM

All available reporting periods
Q1 FY20272026-09-30

Reported figures

Verify material figures against company filings. Market data and AI-assisted analysis may contain errors.